Results 11 to 20 of about 2,661,570 (257)

IFNα and IFNγ Impede Marek’s Disease Progression [PDF]

open access: yes, 2019
Marek’s disease virus (MDV) is an alphaherpesvirus that causes Marek’s disease, a malignant lymphoproliferative disease of domestic chickens. While MDV vaccines protect animals from clinical disease, they do not provide sterilizing immunity and allow ...
Bertzbach, Luca D.   +6 more
core   +1 more source

Progression of Liver Diseases [PDF]

open access: yesHepatitis Monthly, 2012
Dear Editor, To date, the knowledge on the natural history of HCV infection and the risk factors associated with progression of liver disease in children is limited. Progressive liver disease, including hepatocellular carcinoma, is rare but has been reported [1].
openaire   +3 more sources

Risk Factors for Long-Term Coronary Artery Calcium Progression in the Multi-Ethnic Study of Atherosclerosis. [PDF]

open access: yes, 2015
BackgroundCoronary artery calcium (CAC) detected by noncontrast cardiac computed tomography scanning is a measure of coronary atherosclerosis burden. Increasing CAC levels have been strongly associated with increased coronary events.
Blaha, Michael J   +7 more
core   +2 more sources

The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease. [PDF]

open access: yes, 2019
IntroductionClinical trials on preclinical Alzheimer's disease are challenging because of the slow rate of disease progression. We use a simulation study to demonstrate that models of repeated cognitive assessments detect treatment effects more ...
Aisen, Paul S   +4 more
core   +1 more source

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial. [PDF]

open access: yes, 2018
ObjectiveNo evidence of progression or active disease (NEPAD) is a novel combined endpoint defined by the absence of both progression and inflammatory disease activity in primary progressive multiple sclerosis (PPMS).
Belachew, Shibeshih   +10 more
core   +3 more sources

A systematic review of biomarkers for disease progression in Parkinson's disease [PDF]

open access: yes, 2013
Peer reviewedPublisher ...
A Winogrodzka   +33 more
core   +2 more sources

Recent Progress in Thoracic Disease [PDF]

open access: yesThe Boston Medical and Surgical Journal, 1891
n ...
Sears, George G., Bartol, John W.
openaire   +4 more sources

Selective Fetal Growth Restriction in Dichorionic Twin Pregnancies: Diagnosis, Natural History, and Perinatal Outcome. [PDF]

open access: yes, 2020
This study aims to evaluate the natural history, disease progression, and outcomes in dichorionic twins with selective fetal growth restriction (sFGR) according to different diagnostic criteria and time of onset.
Antonakopoulos, N   +5 more
core   +2 more sources

Quantitative Predictive Modelling Approaches to Understanding Rheumatoid Arthritis:A Brief Review [PDF]

open access: yes, 2019
Rheumatoid arthritis is a chronic autoimmune disease that is a major public health challenge. The disease is characterised by inflammation of synovial joints and cartilage erosion, which lead to chronic pain, poor life quality and, in some cases ...
Chaplain, Mark A. J.   +2 more
core   +4 more sources

Metabolome in progression to Alzheimer's disease [PDF]

open access: yesTranslational Psychiatry, 2011
Mild cognitive impairment (MCI) is considered as a transition phase between normal aging and Alzheimer's disease (AD). MCI confers an increased risk of developing AD, although the state is heterogeneous with several possible outcomes, including even improvement back to normal cognition.
Hyötyläinen, Tuulia   +14 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy